Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover efficient nickel-catalyzed synthesis of benzofuranones. A green, solvent-free route offering high purity and cost reduction for pharmaceutical and agrochemical manufacturing.
Patent CN116640108A reveals metal-free synthesis for high-purity 2-vinyl chroman compounds ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel Lewis acid catalyzed route for high-purity imidazoheterocycles. Reduces steps and enhances supply chain reliability for pharmaceutical intermediates globally.
Patent CN1172945C details a streamlined 3-step synthesis of etoposide from glucose. Discover cost-effective manufacturing and high-purity supply chain solutions.
Novel patent CN104230880A enables cost-effective Atorvastatin side chain production. Reliable supplier for pharmaceutical intermediates with scalable green chemistry.
Novel dual-acid catalysis method for cyclamen aldehyde production. High purity, reduced waste, scalable production for fragrance industry supply chain efficiency.
Patent CN110845410B reveals a safe one-pot method for 6,7-dimethoxy-3,4-dihydroisoquinoline HCl using phosphotungstic acid, offering high purity and cost reduction.
Patent CN109053387B details a novel two-step Magnolol synthesis using NbCl5 catalysis. This route offers mild conditions, high selectivity, and significant cost reduction in pharmaceutical intermediates manufacturing.
Analysis of patent CN110818573A reveals mixed-acid catalysis improves MOCA yield and reduces wastewater, offering cost-effective supply chain solutions for polymer manufacturers.
Patent CN111253413A details a green Nb2O5 catalytic route for isosorbide. Achieve >85% yield with reduced waste. Ideal for pharma and polymer intermediates.
Novel patent CN115873002B offers eco-friendly Remdesivir intermediate synthesis. Reduces waste, improves scalability for reliable pharmaceutical intermediate supply chains.
Patent CN108329194B reveals a novel binaphthol aluminum catalyst for citronellal cyclization, offering superior enantioselectivity and simplified industrial recovery.
Patent CN103408502A details a Bronsted acid-catalyzed, metal-free route to quinazolinones using O2. This method ensures high purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Novel Lewis acid catalyzed route for 3-(4-methoxyphenyl)succinimide. High yield, reduced waste, scalable for pharmaceutical intermediate supply chains.
Patent CN116332943A reveals a recyclable ionic liquid catalytic route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN116332943A introduces a recyclable Brønsted acidic ionic liquid catalyst for synthesizing drug intermediates, offering high purity and reduced environmental impact for cost-effective manufacturing.
Novel boric acid-catalyzed route for 4,4-dichlorodiphenyl sulfone. Low temperature, high purity, reduced isomers. Ideal for pharma and polymer industries.
Advanced synthesis of Remdesivir intermediates via optimized cyanation and ammonolysis. Reduces waste and improves scalability for pharmaceutical manufacturing.
Novel acidic resin catalysis for Trifluridine intermediate. Enhances purity above 98 percent, reduces emulsification, ensures scalable supply for pharmaceutical manufacturing.
Patent CN102311352B details a safe, cost-effective 3-step synthesis from m-cresol, offering significant supply chain advantages for high-purity pharmaceutical intermediates.